Barchielli A, Acciai S, Lazzeri V, Buiatti E
Epidemiology Unit, Center for Study and Prevention of Cancer, Florence, Italy.
Eur J Epidemiol. 1997 Feb;13(2):125-32. doi: 10.1023/a:1007323722805.
The study evaluated the overall survival after AIDS diagnosis of 1,014 patients reported to the Italian AIDS Registry as resident in Tuscany, stratified by age, gender, year of diagnosis, HIV transmission category, initial AIDS-defining disease and CD4+ cells count. The study was a population-based survival analysis, carried out through Kaplan-Meier method (mean survival times-MST-, 1, 2 and 3-year observed survival) and Cox models (crude and adjusted relative risk-RR). The MST was 12.4 months for all cases, increasing from 4-7 months in 1985-1987 to 14 months in 1991-1992. The observed survival was 51.4% at the first year of follow-up, 28.4% at the second year and 14.5% at the third year. The multivariate analysis showed an independent prognostic effect of age, year of diagnosis, initial AIDS-defining disease and CD4+ cells count. The prognosis was worse in cases aged over 44 (reference: 25-29), diagnosed before 1988 (reference: 1991) and with wasting syndrome, toxoplasmosis, HIV encephalopathy or multiple diseases (reference: PCP alone); and better in cases with more than 100 CD4+ cells/mm3 (reference: < or = 50 cells/mm3). The differences in gender and among HIV transmission categories disappeared after age-adjustment. The study confirmed, in an European population-based series, the poor long-term AIDS prognosis and, once AIDS has became clinically manifest, the prognostic value of some clinical and demographic variables.
该研究评估了向意大利艾滋病登记处报告的1014名居住在托斯卡纳的患者艾滋病诊断后的总生存期,按年龄、性别、诊断年份、HIV传播类别、初始艾滋病定义疾病和CD4 +细胞计数进行分层。该研究是一项基于人群的生存分析,通过Kaplan-Meier方法(平均生存时间-MST-、1年、2年和3年观察到的生存率)和Cox模型(粗相对风险和调整后的相对风险-RR)进行。所有病例的MST为12.4个月,从1985 - 1987年的4 - 7个月增加到1991 - 1992年的14个月。随访第一年观察到的生存率为51.4%,第二年为28.4%,第三年为14.5%。多变量分析显示年龄、诊断年份、初始艾滋病定义疾病和CD4 +细胞计数具有独立的预后效应。44岁以上(参照:25 - 29岁)、1988年之前诊断(参照:1991年)以及患有消瘦综合征、弓形虫病、HIV脑病或多种疾病(参照:仅肺孢子菌肺炎)的患者预后较差;CD4 +细胞超过100个/mm3的患者(参照:≤50个细胞/mm3)预后较好。年龄调整后,性别和HIV传播类别之间的差异消失。该研究在一个基于欧洲人群的系列研究中证实了艾滋病长期预后较差,并且一旦艾滋病临床表现出来,一些临床和人口统计学变量具有预后价值。